2023: the best year ever for Future Pharmacology (and even better years to come)

Fabrizio Schifano

doi:10.3390/futurepharmacol4010001

2023: the best year ever for Future Pharmacology (and even better years to come)

Research output: Contribution to journal › Editorial › peer-review

6 Downloads (Pure)

Original language	English
Pages (from-to)	1-2
Number of pages	2
Journal	Future Pharmacology
Volume	4
DOIs	https://doi.org/10.3390/futurepharmacol4010001
Publication status	Published - 2 Jan 2024

Keywords

Annual review
Future developments

Access to Document

10.3390/futurepharmacol4010001Licence: CC BY-NC

Final_Version
© 2023 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Final published version, 178 KBLicence: CC BY

Cite this

@article{fa914c98ebc84871a590f940dd5c2f0e,

title = "2023: the best year ever for Future Pharmacology (and even better years to come)",

keywords = "Annual review, Future developments",

author = "Fabrizio Schifano",

note = "{\textcopyright} 2023 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).",

year = "2024",

month = jan,

day = "2",

doi = "10.3390/futurepharmacol4010001",

language = "English",

volume = "4",

pages = "1--2",

journal = "Future Pharmacology",

issn = "2673-9879",

publisher = "MDPI Multidisciplinary Digital Publishing Institute",

}

TY - JOUR

T1 - 2023: the best year ever for Future Pharmacology (and even better years to come)

AU - Schifano, Fabrizio

N1 - © 2023 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

PY - 2024/1/2

Y1 - 2024/1/2

KW - Annual review

KW - Future developments

U2 - 10.3390/futurepharmacol4010001

DO - 10.3390/futurepharmacol4010001

M3 - Editorial

SN - 2673-9879

VL - 4

SP - 1

EP - 2

JO - Future Pharmacology

JF - Future Pharmacology

ER -